Skip to main content

Leslie’s, Inc. Announces Second Quarter 2026 Financial Results

Sales increase of 4.3% and Comparable sales increase of 6.6%  Achieved 8% customer count growth year-over-year Company reiterates full year guidance PHOENIX, May 13, 2026 (GLOBE NEWSWIRE) — Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its financial results for the fiscal second quarter 2026.     “Our comprehensive transformation plan delivered measurable results in the second quarter as we position Leslie’s for sustainable profitable growth. Second quarter performance demonstrated the effectiveness of our strategic initiatives, with revenue growth of 4.3%, comparable sales increase of 6.6% and total customer count growth of 8% year-over-year. The early success of our ‘Price...

Continue reading

Okeanis Eco Tankers Corp. Reports Financial Results for the First Quarter of 2026

ATHENS, Greece, May 13, 2026 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (together with its subsidiaries, unless context otherwise dictates, “OET” or the “Company”) (NYSE: ECO, OSE: OET) today reported its unaudited condensed financial results for the first quarter of 2026, which are attached to this press release. Financial performance of the First Quarter Ended March 31, 2026Revenues of $170.2 million in Q1 2026, compared to $80.1 million in Q1 2025. Profit of $88.3 million in Q1 2026, compared to $12.6 million in Q1 2025. Vessel operating expenses of $12.2 million in Q1 2026, compared to $10.5 million in Q1 2025. Earnings per share of $2.31 in Q1 2026 (based on a weighted average number of shares of 38,161,939 for the period), compared to $0.39 in Q1 2025. Cash (including restricted cash) of $176.5 million as of March 31,...

Continue reading

Caliber Reports First Quarter 2026 Financial Results

First Quarter Platform Revenue and Adjusted EBITDA Loss In Line with Internal Plan; Caliber Reaffirms 2026 Full-Year Guidance SCOTTSDALE, Ariz., May 13, 2026 (GLOBE NEWSWIRE) — Caliber (Nasdaq: CWD), a diversified real estate and digital asset management platform, today reported results for the first quarter ended on March 31, 2026. First quarter Platform revenue and Adjusted EBITDA loss were in line with management’s internal expectations and reflect progress against the Company’s previously announced 2026 plan, with year-over-year Platform revenue growth, a narrower Platform Adjusted EBITDA loss, and tangible execution across both the Company’s capital formation and project financing initiatives. First Quarter 2026 Platform Financial Results (compared to First Quarter 2025)Platform revenue of $4.1 million,...

Continue reading

AmpliTech Group Reports Strong First Quarter 2026 Revenue Growth and Significant Q1 Gross Margin Expansion YoY

HAUPPAUGE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGR, AMPGZ), a designer, developer, and manufacturer of advanced radio frequency (RF) microwave components, 5G communication systems and Quantum computing LNAs, today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 HighlightsRevenue increased 48.6% year-over-year to $5.35 million, compared to $3.60 million in the first quarter of 2025. Gross profit increased 116.1% year-over-year to $2.57 million from $1.19 million in the prior- year period. Gross margin improved significantly to 48.0%, compared to 33.0% in the prior-year period. Manufacturing and engineering segment revenue increased to $3.28 million from $0.99 million in the prior-year quarter. Net loss improved 17.3% year-over-year to $(1.52) million. Cash,...

Continue reading

Armlogi Holding Corp. Reports Third Quarter and First Nine Months of Fiscal Year 2026 Financial Results

WALNUT, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today reported its financial results for the third quarter and first nine months of fiscal year 2026, ended March 31, 2026. For the first nine months of fiscal year 2026, total revenue increased 2.3% year-over-year to $142.7 million, driven by 19.9% growth in warehousing services revenue, which reached $55.5 million. Transportation services revenue declined 6.4% to $87.1 million, reflecting a continued shift in customer mix toward cross-border e-commerce platforms that bundle delivery services. The Company recorded a net loss of $15.4 million, or...

Continue reading

Energous Wireless Power Solutions Reports First Quarter 2026 Results

 – Reports Revenue of $3.1 Million – Posting Fifth Consecutive Quarter of Revenue Growth – Conference Call Today at 4:30 p.m. Eastern Time SAN JOSE, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Energous Corporation d/b/a Energous Wireless Power Solutions (Nasdaq: WATT) (“Energous,” the “Company,” “we,” or “our”), a pioneer in scalable, over-the-air wireless power networks, today announced financial results for the first quarter ended March 31, 2026, reporting revenue of approximately $3.1 million, representing a 1% increase versus the fourth quarter of 2025, and a 799% improvement versus the same prior year period. The Company also provided an update on recent events and Company highlights. “The first quarter of 2026 marked a defining moment in Energous’ evolution,” said Mallorie Burak, CEO and CFO of Energous. “Having successfully...

Continue reading

Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts

The registrational intent ACR-368 Phase 2b study is advancing with a prespecified simultaneous interim analysis and data update for both all-comer (biopsy-independent) serous endometrial cancer arms in second half 2026  The ACR-2316 Phase 1/2 study is advancing towards expansion phase demonstrating favorable tolerability, primarily transient neutropenia, with durable clinical activity at weekly dosing regimens in subjects with AP3-prioritized tumors, including heavily pretreated lung cancers Cash, cash equivalents, and marketable securities of $97.7 million as of March 31, 2026, plus proceeds of $7.3 million from subsequent equity financing, expected to fund operations into third quarter of 2027 and through multiple anticipated clinical milestones WATERTOWN, Mass., May 13, 2026 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon”...

Continue reading

Motorsport Games Reports First Quarter 2026 Financial Results

Motorsport Games Reports First Quarter 2026 Financial ResultsMotorsport Games Q1 2026: revenue $4.0M (+129%), Adj. EBITDA $1.5M, record 8,800 player peak on Le Mans Ultimate.MIRAMAR, Fla., May 13, 2026 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) today reported financial results for its first quarter ended March 31, 2026. The Company has also posted the first quarter 2026 earnings slides highlighting key milestones that occurred during and subsequent to the period, which are accessible on the Company’s investor relations website. “We are very pleased to report another quarter of strong financial performance, with revenues more than doubling year on year. The progress we have made in transforming this business is now visibly consistent. We have once again generated positive...

Continue reading

Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2026 Results

ROSEVILLE, Minn., May 13, 2026 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 29, 2026. Fourth Quarter Fiscal Year 2026 Highlights:Record fourth quarter sales of $265.9 million, an 8% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 16% over the same quarter in the prior year. All segments grew revenue in the fourth quarter 2026. Record fourth quarter gross profit of $54.2 million, a 4% increase over the same quarter of the prior year. Fourth quarter diluted earnings per share (EPS) of $0.74, a decrease of $0.04, or 5%, due primarily to an approximately $4.4 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed...

Continue reading

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, 2026 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today reported financial results for the first quarter ended March 31, 2026, and provided business highlights. “We continue to work diligently to advance vopimetostat towards pivotal development in pancreatic cancer and remain highly encouraged by the potential of the ongoing study of vopimetostat in combination with RAS(ON) inhibitors,” said Malte Peters, M.D., Chief Executive Officer. “With a recently strengthened leadership...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.